by Gemma Escarré,
The Spanish Bioindustry Association (Asebio) presented the Asebio Report 2017 with the latest data on the Spanish biotechnology sector on 9 July in Madrid.
One of the most noteworthy figures is the investment raised, €150 million, up 17% from 2016. Also, the sector's impact on the economy as a whole, generating 7.8% of the GDP and 108,000 jobs.
The number of companies in the sector has dropped by more than 200, from 2,981 to 2,767 in 2016. By area of activity, 66.8% focus on human health and 23.5% on food. R&D investment totalled €617 million, up 6.6% from 2016, a figure that once again shows the private sector's commitment to research and innovation.
By autonomous community, those with the greatest percentage of biotechnology companies are Catalonia (19.3%), Andalusia (13.5%) and Galicia (8.6%).
In 2017, 856 patents were published in the sector.
After this analysis, with a panorama of ups and downs, Asebio shared proposals that contribute to address the limitations of the Spanish R&D system.
CataloniaBio & HealthTech recently presented its Study on investment in the Biomedical industry in Catalonia 2017.
Photo: Jordi Martí, president of Asebio and CEO of Ferrer - © Asebio